Dublin, May 12, 2023 (GLOBE NEWSWIRE) The "Molecular Diagnostics at the Point of Care. By Application, Technology, Place, Product and by Country. With.
/PRNewswire/ The "Latent TB Diagnostics Global Markets by Assay, by Risk Factor, and by Lab/Place. With Executive and Consultant Guides and Market Analysis.
/PRNewswire/ The "Genomic Cancer Panel and Profiling Markets by Cancer, by Application, by Tissue and by Gene Type with Screening Potential Market Size,.
/PRNewswire/ The "Liquid Biopsy Markets by Cancer, Usage, Biomarker, Place, & Product With Price and Volume Outlook. Including Executive and Consultant.